Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jyothi Vijayaraghavan

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Advances in Experimental Medicine and Biology|July 22, 2018
Notch and T Cell Function - A Complex TaleJyothi Vijayaraghavan, Barbara A Osborne
American Journal of Physiology. Endocrinology and Metabolism|May 15, 2014
miR-24 regulates menin in the endocrine pancreasJyothi Vijayaraghavan, Elaine C Maggi, Judy S Crabtree
Frontiers in Immunology|October 9, 2024
Editorial: Treating solid organ diseases with innovative chimeric-antigen receptor T-cells: current indications, progress, limitations and potential strategiesElizabeth Quackenbush, Jyothi Vijayaraghavan, Emrah Ilker Ozay, et al.
Oncotarget|September 3, 2016
Acquisition of an oncogenic fusion protein serves as an initial driving mutation by inducing aneuploidy and overriding proliferative defectsJacob M Loupe, Patrick J Miller, Benjamin P Bonner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 17, 2016
Intracellular Delivery of Anti-pPKCθ (Thr538) via Protein Transduction Domain Mimics for ImmunomodulationE Ilker Ozay, Gabriela Gonzalez-Perez, Joe A Torres, et al.
Frontiers in Immunology|February 4, 2020
Differentiation of Pathogenic Th17 Cells Is Negatively Regulated by Let-7 MicroRNAs in a Mouse Model of Multiple SclerosisConstance C Angelou, Alexandria C Wells, Jyothi Vijayaraghavan, et al.
Stem Cell Research|February 10, 2019
Cymerus™ iPSC-MSCs significantly prolong survival in a pre-clinical, humanized mouse model of Graft-vs-host diseaseE Ilker Ozay, Jyothi Vijayaraghavan, Gabriela Gonzalez-Perez, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Advances in Experimental Medicine and Biology|July 22, 2018
Notch and T Cell Function - A Complex TaleJyothi Vijayaraghavan, Barbara A Osborne
American Journal of Physiology. Endocrinology and Metabolism|May 15, 2014
miR-24 regulates menin in the endocrine pancreasJyothi Vijayaraghavan, Elaine C Maggi, Judy S Crabtree
Frontiers in Immunology|October 9, 2024
Editorial: Treating solid organ diseases with innovative chimeric-antigen receptor T-cells: current indications, progress, limitations and potential strategiesElizabeth Quackenbush, Jyothi Vijayaraghavan, Emrah Ilker Ozay, et al.
Oncotarget|September 3, 2016
Acquisition of an oncogenic fusion protein serves as an initial driving mutation by inducing aneuploidy and overriding proliferative defectsJacob M Loupe, Patrick J Miller, Benjamin P Bonner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 17, 2016
Intracellular Delivery of Anti-pPKCθ (Thr538) via Protein Transduction Domain Mimics for ImmunomodulationE Ilker Ozay, Gabriela Gonzalez-Perez, Joe A Torres, et al.
Frontiers in Immunology|February 4, 2020
Differentiation of Pathogenic Th17 Cells Is Negatively Regulated by Let-7 MicroRNAs in a Mouse Model of Multiple SclerosisConstance C Angelou, Alexandria C Wells, Jyothi Vijayaraghavan, et al.
Stem Cell Research|February 10, 2019
Cymerus™ iPSC-MSCs significantly prolong survival in a pre-clinical, humanized mouse model of Graft-vs-host diseaseE Ilker Ozay, Jyothi Vijayaraghavan, Gabriela Gonzalez-Perez, et al.
Pageof 1